Literature DB >> 3829045

Heterogeneous expression of a murine B16 melanoma-associated antigen correlates with cell cycle.

S P Leong, P D Noguchi, R E Cunningham, T Takami, J A Roth.   

Abstract

A murine monoclonal antibody (MM2-3C6) that reacts with a B16 murine melanoma-associated membrane antigen was used to study the relationship of antigen expression to the cell cycle. Dual-parameter flow cytometric measurements of membrane antigen and DNA revealed that antigen-positive cells were present throughout the cell cycle. Peak antigenic expression was noted during the late log phase of the cell growth curve with negligible antigen-negative population. The emergence of a distinct antigen-negative population (30%-40%) was noted in the late stationary phase. Cell cycle analysis indicated that the negative subpopulation was restricted to the G0/G1 phase, thus, demonstrating antigenic heterogeneity within the tumor cell population. Cell sorting was performed to analyze the origin of such heterogeneity. Following two sequential sortings, the antigen-negative cells became antigenic upon reculture. Again, at the late stationary phase, a distinct antigen-negative population (30%-40%) emerged. The sorted antigen-positive cells showed flow cytometric profiles identical to the sorted antigen-negative population upon reculture. Therefore, in this murine model, it appears that antigen expression is cell cycle dependent and such expression seems to be associated with proliferation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3829045     DOI: 10.1007/bf00205586

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  25 in total

1.  Mechanism of tumor cell resistance to lysis by syngeneic lymphocytes.

Authors:  I J Fidler; C Bucana
Journal:  Cancer Res       Date:  1977-11       Impact factor: 12.701

Review 2.  Flow cytometry in clinical cancer research.

Authors:  B Barlogie; M N Raber; J Schumann; T S Johnson; B Drewinko; D E Swartzendruber; W Göhde; M Andreeff; E J Freireich
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

3.  Antigen expression in human melanoma cells in relation to growth conditions and cell-cycle distribution.

Authors:  T Lindmo; C Davies; E K Rofstad; O Fodstad; A Sundan
Journal:  Int J Cancer       Date:  1984-02-15       Impact factor: 7.396

4.  Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.

Authors:  S W Burchiel; J C Martin; K Imai; S Ferrone; N L Warner
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

5.  Heterogeneity and clonal variation related to cell surface expression of a mouse lung tumor-associated antigen quantified using flow cytometry.

Authors:  D W Bahler; E M Lord; S J Kennel; P K Horan
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

6.  Cell-cycle dependent appearance of murine leukemia-sarcoma virus antigens.

Authors:  S Panem; V Schauf
Journal:  J Virol       Date:  1974-06       Impact factor: 5.103

7.  Relationship between antigen density and immunotherapeutic response elicited by monoclonal antibodies against solid tumors.

Authors:  P M Capone; L D Papsidero; T M Chu
Journal:  J Natl Cancer Inst       Date:  1984-03       Impact factor: 13.506

8.  Enhanced expression of melanoma-associated antigens and beta 2-microglobulin on cultured human melanoma cells by interferon.

Authors:  S K Liao; P C Kwong; M Khosravi; P B Dent
Journal:  J Natl Cancer Inst       Date:  1982-01       Impact factor: 13.506

9.  Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation.

Authors:  D W Kufe; L Nadler; L Sargent; H Shapiro; P Hand; F Austin; D Colcher; J Schlom
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

Review 10.  Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies.

Authors:  P A Edwards
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

View more
  1 in total

Review 1.  Monoclonal antibodies in neuro-oncology.

Authors:  D Stavrou
Journal:  Neurosurg Rev       Date:  1990       Impact factor: 3.042

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.